Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood (Q36497457)

14 August 2017

Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood (English)

1 reference

14 August 2017

metastatic breast cancer

1 reference

20

Kurtis E Bachman

0 references

Vered Stearns

13

object named as

Vered Stearns

1 reference

14 August 2017

18

Pedram Argani

1 reference

14 August 2017

Michaela J Higgins

1

1 reference

14 August 2017

Danijela Jelovac

2

1 reference

14 August 2017

Evan Barnathan

3

1 reference

14 August 2017

Brian Blair

4

1 reference

14 August 2017

Shannon Slater

5

1 reference

14 August 2017

Penny Powers

6

1 reference

14 August 2017

Jane Zorzi

7

1 reference

14 August 2017

Stacie C Jeter

8

1 reference

14 August 2017

George R Oliver

9

1 reference

14 August 2017

John Fetting

10

1 reference

14 August 2017

Leisha Emens

11

1 reference

14 August 2017

Carol Riley

12

1 reference

14 August 2017

Frank Diehl

14

1 reference

14 August 2017

Philipp Angenendt

15

1 reference

14 August 2017

Peng Huang

16

1 reference

14 August 2017

Leslie Cope

17

1 reference

14 August 2017

Kathleen M Murphy

19

1 reference

14 August 2017

Joel Greshock

21

1 reference

14 August 2017

Antonio C Wolff

22

1 reference

14 August 2017

Ben H Park

23

1 reference

14 August 2017

language of work or name

English

0 references

publication date

15 March 2012

1 reference

14 August 2017

Clinical Cancer Research

1 reference

14 August 2017

18

1 reference

14 August 2017

3462-3469

1 reference

14 August 2017

12

1 reference

Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

The selective class I PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Tumour evolution inferred by single-cell sequencing

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

PIK3CA mutation associates with improved outcome in breast cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Circulating mutant DNA to assess tumor dynamics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Mutation of the PIK3CA oncogene in human cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Detection and quantification of mutations in the plasma of patients with colorectal tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Multiplexed assays for detection of mutations in PIK3CA.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

BEAMing up for detection and quantification of rare sequence variants.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

The PIK3CA gene is mutated with high frequency in human breast cancers.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533370

Mutation of the PIK3CA gene in ovarian and breast cancer

21 September 2018

1 reference

12 December 2020

Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis

1 reference

12 December 2020

Phenotype of bone metastases of non-small cell lung cancer: epidermal growth factor receptor expression and K-RAS mutational status

1 reference

12 December 2020

Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women

1 reference

12 December 2020

10.1158/1078-0432.CCR-11-2696

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

1 reference